No matter where u move 200 day average
U r luck if this holds at 200 line
Most stocks finish their downtrend way below 200
0.60 Might be a good support for cemi
CBRX was trading around 0.60
When they had $32m Cash
Around $45m market cap
And $30m revenue And deal signed with merck untill
Let the chart lead you not pumpers here
And I can't even see where the bottom and base
I was long this shiet long time, and I was one of the posters here who questioned managements r/s decision
Management team knew what was coming I wouldn't be surprised to see llawsuits by investors
Again I am nobody, there are people here with soo much knowledge
and you cALL CEMI an investment at this point?
explain it to me why cemi is an investment please, l will place my bid if you tell me just one good reason how cemi will have increasing revenue and net income for next 3 q?
Of course they knew about Determine Combo. Investors should have known, too, which they clearly didn't. Should CEMI have warned investors? Had they done so, they wouldn't be sitting on nearly $9 million of cash. They did the r/s and nasdaq listing because they wanted access to capital on favorable terms, which they got.
They aren't doing what they doing to rip off shareholders. They're doing it to try and build the company. Sometimes you have to do what you have to do. That's business.
I wanted to point out there is nothing to either pump or bash about this stock. It is simply an established company that is growing numerically, not exponentially (no break out products close to approval). But more than that, they cannot break out until they get control of the reagents that are used for their testing. The antigens (and thereby the antibodies to the antigens) are all other institutions reagents. Those other institutions are all getting the royalty payments that would otherwise be supporting in house R&D for new products. Worked for Baxter Travenol which had 20 years of compounded 20% growth in sales from the 1960s through the 1980s. When I joined them in 1971 they sold $270 million. When I left in 1980 they had $3 billion. Draw the curve in between. Their main products were medical devices made from plastic, solutions, blood fractionation products, Fenwal Transfusion/blood separation products and specialty kits for physicians to order drugs and supplies into their own treatment kits. They sold off Hyland Diagnostics, Medtronics, Flint Pharmaceuticals and Wallerstein Fermentation products. But CEMI has to get a proprietary grip on their own technology or expand their DPP contract capabilities exponentially.